Importantly, VSV-NDV treatment also induced a systemic enhancement of T cell responses in peripheral blood and in the spleen, and CD8+ T cell depletion completely reversed VSV-NDV-mediated anti-tumor effects, elucidating a critical mechanism of action of this form of therapy. Here, CD8A is linked to neoplasm.